First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
about
Resistance mechanismsNHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007CTX-M Enzymes: Origin and Diffusion.Detection of Salmonella enterica isolates producing CTX-M Cephalosporinase in U.S. livestock populations.Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United StatesEvaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases.Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of PolandAntimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.ESBLs: A Clear and Present Danger?CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United StatesEmergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuriaPrevalence of bla (CTX M) extended spectrum beta lactamase gene in enterobacteriaceae from critical care patients.Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.Sequence analysis of genes mediating extended-spectrum beta-lactamase (ESBL) production in isolates of Enterobacteriaceae in a Lagos Teaching Hospital, NigeriaRecent Emergence of Escherichia coli with Cephalosporin Resistance Conferred by blaCTX-M on Washington State Dairy FarmsComparison of Extended-Spectrum β-Lactamase (ESBL) CTX-M Genotypes in Franklin Gulls from Canada and ChileClinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United StatesHigh Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands.Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population.Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinationsRisk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors.Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar.Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipientEpidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.Antimicrobial resistance in hospitals: how concerned should we be?Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamasesChanges in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance.Clinical significance of extended-spectrum beta-lactamases.Impact of therapeutic treatment with beta-lactam on transfer of the bla(CTX-M-9) resistance gene from Salmonella enterica serovar Virchow to Escherichia coli in gnotobiotic ratsCTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA.Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania.Characteristics of Quinolone Resistance in Escherichia coli Isolates from Humans, Animals, and the Environment in the Czech Republic
P2860
Q28069941-B4599EEE-F161-4986-A636-7A696D0F53BAQ28298371-64283AEC-4A7B-41D1-B5BB-5B8144556E5DQ30415141-8DCB7998-F284-461A-8AFF-AD7E46EB7B4AQ30420290-62DA589C-3A83-4D2D-B508-26A209C06005Q30580647-E553632C-86A3-42A5-84FC-7631D4248480Q34026758-F2F38ED0-7C87-4397-B5D3-BC5DC0A44AF7Q34045397-1ECE31A6-E4F7-400E-9168-469E023DE581Q34045460-87EE174D-C594-4189-A3DE-B5D78AFEF7EDQ34290139-61192D84-2B9F-4F72-ADDB-219B1820E0E9Q34432199-F1220A34-A7A5-4616-AFEE-33E414F9DD20Q34752032-D20DAA44-05AC-4C0C-813E-CD8ABAAE4DF6Q35101453-7FA80BC1-5D74-4E1F-8798-A8BE1F561E02Q35482523-27CDFF11-E57A-4763-AEDA-94ECC49BD72EQ35600060-1911D039-EEAF-4F17-8133-A3255F4040ADQ35646207-9F6AD0CC-B48F-4EEF-AD2A-41030DB43CD1Q35656192-E0226BD1-1229-49FC-BC05-CF15D2D72F1EQ35684566-79324E0C-5172-4740-8D99-8FFF658B745DQ35764110-026B884C-1D3B-440C-B67B-53F6F5773784Q35819191-16297CE2-AAEB-45F3-A19C-AC88446B60B7Q35867321-D07B5F11-BAFC-459C-B3A1-D37618A1DFB3Q35869239-7A5C4960-6B2C-4E75-ACDA-8797ADB3838EQ35941378-015207B6-68CA-40CC-89A7-FDE1A31C81AEQ36172561-3ADEA934-10E3-4F3E-8E05-899484ED831AQ36282516-4B5C37E5-F83D-4BAA-87CE-37E566CB45A8Q36364145-4AC55D99-39C1-4ED0-9BF2-B60D94266BB0Q36517575-17CB963A-0E7F-4DCD-A0D0-44A5B05B9178Q36565758-DA75C6EB-5688-4E7D-8CDB-3B47A82F83E5Q36932909-E1FE92D1-2701-44A4-992D-CFB4D35A7169Q36949536-93233D28-ED1A-4D62-BAB2-63BE1DD52FA9Q37032821-E1D95077-B4B9-4577-8EC9-E18167F3C9B7Q37036459-58838A99-B056-4B23-B708-9B43DC18757BQ37088893-51A5482E-A7C8-4C35-BC6F-E2671981AFECQ37115833-46216642-22CA-47E5-8EE2-5622BBD24DA8Q37120191-EA586B46-DC73-4048-AF0C-F6651B7D2B9FQ37287890-40367B76-9585-473A-BEE1-468825D73FA6Q37291354-E8DEFC34-F9B0-4031-A556-0E501921455EQ37333242-84E32DA6-A18B-4F2A-8EC3-93F6E8BEC8A3Q37335144-4DC8C409-737E-4010-80F3-66F52EE28E50Q37409886-66CBFBB9-CF13-4891-9378-A4129789FED3Q37570567-3570F637-F13A-4AA6-B321-459D0DE74B13
P2860
First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
First report of the emergence ...... in a U.S. health care system.
@en
type
label
First report of the emergence ...... in a U.S. health care system.
@en
prefLabel
First report of the emergence ...... in a U.S. health care system.
@en
P2093
P2860
P356
P1476
First report of the emergence ...... in a U.S. health care system.
@en
P2093
Brian Wickes
James H Jorgensen
James S Lewis
Jan E Patterson
Monica Herrera
P2860
P304
P356
10.1128/AAC.00576-07
P407
P577
2007-08-27T00:00:00Z